Clostridium difficile Infection in the Emergency Department.


Journal

Journal of clinical gastroenterology
ISSN: 1539-2031
Titre abrégé: J Clin Gastroenterol
Pays: United States
ID NLM: 7910017

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 14 8 2019
medline: 25 6 2021
entrez: 13 8 2019
Statut: ppublish

Résumé

Clostridioides difficile infection (CDI) is associated with substantial emergency department (ED) and inpatient burden. To date, few studies have evaluated the ED burden of CDI. Using the Nationwide Emergency Department Sample, we evaluated trends in ED use, ED and inpatient charges, admission and mortality rates, length of stay, and independent risk factors for hospital admission and mortality after an ED visit. Using Nationwide Emergency Department Sample for 2006 through 2014, we identified all patients with the primary diagnosis of CDI (using diagnostic codes). We determined the trends in ED visits and used survey logistic regression analysis to identify factors associated with hospital admission. Overall, 909,236 ED visits for CDI resulted in 817,935 admissions (90%) to the hospital. The number of visits increased from 76,709 in 2006 to 106,869 in 2014, and the admission rate decreased from 92.4% to 84.4%. ED charges adjusted for inflation went up from US$1433.0 to 2900, a significant rise even accounting for inflation. The overall length of hospital stay decreased from 7 to 5.8 days. Independent predictors of admission after ED visits included smoking, use of alcohol, and presence of multiple comorbidities. Independent risk factors for mortality in admitted patients include increasing age and presence of comorbidities. Although ED use for CDI increased, rates of hospital admission decreased over 9 years. Identification of predictors of admission and in-hospital mortality will help guide policies and interventions to reduce the burden on health care resources.

Identifiants

pubmed: 31403981
doi: 10.1097/MCG.0000000000001252
pii: 00004836-202004000-00011
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

350-355

Références

Heinlen L, Ballard JD. Clostridium difficile infection. Am J Med Sci. 2010;340:247–252.
Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23:529–549.
Jacob J, Wu J, Han J, et al. Clostridium difficile in an urban, university-affiliated long-term acute-care hospital. Infect Control Hosp Epidemiol. 2017;38:294–299.
Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–834.
Zarowitz BJ, Allen C, O’Shea T, et al. Risk factors, clinical characteristics, and treatment differences between residents with and without nursing home- and non-nursing home-acquired Clostridium difficile infection. J Manag Care Spec Pharm. 2015;21:585–595.
Kwok CS, Arthur AK, Anibueze CI, et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107:1011–1019.
Deshpande A, Pant C, Olyaee M, et al. Hospital readmissions related to Clostridium difficile infection in the United States. Am J Infect Control. 2018;46:346–347.
Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466–472.
Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107:89–95.
Heidelbaugh JJ, Kim AH, Chang R, et al. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012;5:219–232.
Centers for Disease Control and Prevention OAPUS, Centers for Disease Control and Prevention, “Outpatient Antibiotic Prescriptions—United States, 2013,” Centers for Disease Control and Prevention, “Outpatient Antibiotic Prescriptions—United States, 2012,” Centers for Disease Control and Prevention, “Outpatient Antibiotic Prescriptions—United States, 2011”. Available at: https://www.cdc.gov/antibiotic-use/community/pdfs/Annual-ReportSummary_2011.pdf. Accessed April 13, 2018.
Baggs J, Fridkin SK, Pollack LA, et al. Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012. JAMA Intern Med. 2016;176:1639–1648.
McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect. 2012;18:282–289.
Bellolio MF, Heien HC, Sangaralingham LR, et al. Increased computed tomography utilization in the emergency department and its association with hospital admission. West J Emerg Med. 2017;18:835–845.
McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66:987–994.
Shrestha MP, Bime C, Taleban S. Decreasing Clostridium difficile-associated fatality rates among hospitalized patients in the United States: 2004-2014. Am J Med. 2018;131:90–96.
Mack M. What drives rising health-care costs? Government Finance Review. 2016. Available at: https://www.gfoa.org/sites/default/files/GFR081626.pdf.
Luo R, Barlam TF. Ten-year review of Clostridium difficile infection in acute care hospitals in the USA, 2005-2014. J Hosp Infect. 2018;98:40–43.
Lee HC, Kim KO, Jeong YH, et al. Clinical outcomes in hospitalized patients with Clostridium difficile infection by age group. Korean J Gastroenterol. 2016;67:81–86.
Daniel A, Rapose A. The evaluation of Clostridium difficile infection (CDI) in a community hospital. J Infect Public Health. 2015;8:155–160.
Khanna S, Aronson SL, Kammer PP, et al. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study. Mayo Clin Proc. 2012;87:636–642.
Rogers MA, Greene MT, Saint S, et al. Higher rates of Clostridium difficile infection among smokers. PLoS One. 2012;7:e42091.
Lee SH, Yun Y, Kim SJ, et al. Association between cigarette smoking status and composition of gut microbiota: population-based cross-sectional study. J Clin Med. 2018;7:282.
Bartlett JG. Clostridium difficile: progress and challenges. Ann N Y Acad Sci. 2010;1213:62–69.
Sapkota AR, Berger S, Vogel TM. Human pathogens abundant in the bacterial metagenome of cigarettes. Environ Health Perspect. 2010;118:351–356.
Charilaou P, Devani K, John F, et al. Acute kidney injury impact on inpatient mortality in Clostridium difficile infection: a national propensity-matched study. J Gastroenterol Hepatol. 2018;33:1227–1233.
Tariq R, Law CCY, Khanna S, et al. The impact of Clostridium difficile infection on mortality in patients with inflammatory bowel disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2019;53:127–133.
Becerra MB, Becerra BJ, Banta JE, et al. Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the nationwide inpatient sample. BMC Infect Dis. 2015;15:254.
Scheurer DB, Hicks LS, Cook EF, et al. Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect. 2007;135:1010–1013.

Auteurs

Sushil K Garg (SK)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester.

Itegbemie Obaitan (I)

Departments of Internal Medicine.

Shashank Sarvepalli (S)

Department of Hospital Medicine, Cleveland Clinic, Cleveland, OH.

Chimaobi M Anugwom (CM)

Gastroenterology and Hepatology, University of Minnesota, Twin Cities, MN.

Darrell S Pardi (DS)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester.

Sahil Khanna (S)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH